EANS-Adhoc: CompuGroup Medical AG / signs new 300 million euro credit facility

ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.

22.12.2010

Koblenz: Today CompuGroup Medical AG has signed an agreement with SEB AG as Bookrunner, sole underwriter and Mandated Lead Arranger for a new syndicated loan. The new credit facility with a total volume of 300 million euro consists of a term loan of 160 million euro and a revolving credit facility of up to 140 million euro, both with a 5 year tenor. The financing will be used to refinance existing liabilities as needed and provides significant additional financial scope for further acquisitions.

"The positive feedback from the investing financial institutions confirms that we are a powerful and well-positioned growth company in a dynamic environment", said Christian B. Teig, Chief Financial Officer of CompuGroup Medical AG. "We are solidly financed for the next years and now have the basis to continue with our profitable growth strategy."

End of ad-hoc announcement

end of announcement euro adhoc

issuer: CompuGroup Medical AG Maria Trost 21 D-56070 Koblenz phone: +49 (0) 261 8000-0 FAX: +49 (0) 261 8000-1166 mail: investor@cgm.com WWW: www.cgm.com sector: Software ISIN: DE0005437305 indexes:

stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Hamburg, Stuttgart, Düsseldorf, München
language: English

Rückfragen & Kontakt:

Ralf Glass
Vicepresident CEO support
T +49 (0) 160 3630315
E-Mail: ralf.glass@cgm.com

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS | OTB0008